Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke

NCT05369533 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05369533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05369533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke
Lead sponsor
University of California, Los Angeles
Phase
Phase 1/2
Overall status
Completed
Start date
August 1, 2022
Completion date
March 11, 2024
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke